Cited by 80Alzheimer's disease research and treatmentsMitochondrial Function and PathologyAntioxidants, Aging, Portulaca oleracea

Alzheimer’s Disease-Like Pathology in Senescence-Accelerated OXYS Rats Can Be Partially Retarded with Mitochondria-Targeted Antioxidant SkQ1

Open access
Stefanova, Natalia A., Muraleva, Natalia A., Skulachev, Vladimir P., Kolosova, Nataliya G.·2013·Journal of Alzheimer's Disease

Abstract

We previously showed that mitochondria-targeted antioxidant SkQ1 (plastoquinonyl-decyltriphenylphosphonium) at nanomolar concentrations is capable of preventing and slowing down some cerebral dysfunctions in accelerated-senescence OXYS rats. Here we demonstrate that OXYS rats develop behavior, learning, and memory deficits against a background of neurodegeneration signs detected by magnetic resonance tomography and amyloid-β (Aβ) pathology similar to those seen in Alzheimer's disease (AD). Long-term treatment with SkQ1 (250 nmol/kg body weight daily from the age of 1.5 to 23 months) reduced the age-related alterations in behavior and spatial memory deficit in Morris water maze in OXYS and Wistar rats. Furthermore, this is the first report that SkQ1 treatment slows down pathological accumulation of AβPP, Aβ, and hyperphosphorylation of tau-protein in OXYS rats, as well as age-dependent changes in healthy Wistar rats. Our results support the possibility of using the OXYS strain as a rat model of AD-like pathology. It seems probable that the mitochondria-targeted antioxidant SkQ1 can be a good prophylactic strategy to maintain brain health and to treat AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jad-131034

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AD-related cognitive decline, behavioural test scores and senescence-associated myocardial disease may improve in murine models upon long-term or limited intake of SkQ1.

    “Finally, AD-related cognitive decline, behavioural test scores and senescence-associated myocardial disease may improve in murine models upon long-term (lifelong) or limited (between 12 and 18 months of age) intake of SkQ1 [77,78,99,100,101].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Stefanova, N. A., Muraleva, N. A., Skulachev, V. P., & Kolosova, N. G.
Affiliations
  • Institute of Cytology and Genetics (RU)
  • Lomonosov Moscow State University (RU)
Venue
Journal of Alzheimer's Disease
Published
2013-11-25
Volume
38
Issue
3
Pages
681-694
ISSN
  • 1387-2877 (ISSN-L)
  • 1875-8908
OpenAlex
W1643376448
Cited by
80
References
48
Citations by year
2026: 4 · 2025: 4 · 2024: 6 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 6 · 2019: 4 · 2018: 8 · 2017: 8 · 2016: 8 · 2015: 10 · 2014: 11
FWCI
6.72
Type
journal article
Language
en
Open access
Locations
  • Journal of Alzheimer s Disease (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • Russian Foundation for Basic Research (11-04-00666)
  • Russian Academy of Sciences (11-04-00666)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Antioxidants, Aging, Portulaca oleracea
Keywords
Alzheimer's disease
MeSH terms
Age Factors, Aging, Alzheimer Disease, Animals, Antioxidants, Brain, Cognition Disorders, Disease Models, Animal, Male, Memory Disorders, Mitochondria, Plastoquinone, Rats, Mutant Strains, Space Perception, Rats, Wistar, Maze Learning, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review